STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

STAAR Surgical CompanyNASDAQ: STAA

Depreciation & Amortization · Q1 FY2026 · quarter ended Apr 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of $2.21M fell 5.4% year over year, behind the +7.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 8.5% from the prior quarter. Over 3 fiscal years it compounded at +22.6% a year.

Context

  • Depreciation & amortization amounted to 3.5% of revenue in FY2025, up 1.3 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -5.4% toward the trailing-twelve-month pace of +7.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$2.21M-8.5% QoQ
Last fiscal yearJan 2026
$8.32M+20.7% YoY
LTMApr 2026
$8.6M+7.6% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.4%——
1 year+20.7%——
3-year CAGR+22.6%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
8.32M USD
Year-over-year change
+20.7%
4-year CAGR
+22.9%

Depreciation & Amortization vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 depreciation & amortization of $8.6M is the 4th largest of the 5 companies compared; the peer median is $397.5M.
  • Its year-over-year change of +7.6% is the 2nd highest of 5, against a peer median of +2.6%.
  • Depreciation & amortization amounts to 3.0% of revenue for STAA, versus a peer median of 8.4%.
STAA Competitors Peer median
Depreciation & Amortization for STAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$1.84B +41.7%+5.9%16.9%
BLCOBausch + Lomb CorporationLTM Jun 2026$411M -4.2%+3.6%7.7%
COOThe Cooper Companies, Inc.LTM Jul 2026$384M +3.8%+6.9%9.1%
STAASTAAR Surgical CompanyLTM Apr 2026$8.6M +7.6%+22.6%3.0%
RXSTRxSight, Inc.LTM Mar 2026$3.32M +1.4%-6.7%2.6%
Peer median (excluding STAA) $397.5M+2.6%+4.7%8.4%

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Net Income27.51M39.01M21.35M(20.21M)(80.45M)
Depreciation & Amortization3.64M4.51M5.12M6.89M8.32M
Deferred Income Tax(1.52M)(1.34M)3.26M3.59M(2.92M)
Stock-Based Compensation14.61M20.37M23.52M27.21M30.59M
Change in Working Capital(2.39M)(29.13M)(40.84M)(5.4M)(16.33M)
Accounts Receivables(8.87M)(19.6M)(32.76M)16.49K27.83M
Inventory66K(7.94M)(14.36M)(10K)(16.98M)
Accounts Payables108K1.81M(701K)75(5.51M)
Other Working Capital6.3M(3.39M)6.98M(5.41M)(21.67M)
Other Non-Cash Items2.11M2.3M2.18M3.64M26.55M
Operating Cash Flow43.96M35.72M14.59M15.73M(34.23M)
Capital Expenditures(13.65M)(18.11M)(18.19M)(23.39M)(5.82M)
Acquisitions (Net)0138.27M000
Purchases of Investments0(155.75M)(52.31M)(80.24M)(75.36M)
Sales of Investments017.48M144.85M44.42M127.32M
Other Investing Activities0(138.27M)00198K
Investing Cash Flow(13.65M)(156.38M)74.35M(59.22M)46.34M
Debt Repayment(1.65M)(126K)(161K)(165K)(42K)
Common Stock Issued1K1K1K2K3.47M
Common Stock Repurchased00(2.1M)(1.51M)(6.46M)
Dividends Paid00000
Other Financing Activities19.44M8.42M9.67M7.39M(1.52M)
Financing Cash Flow17.79M8.3M7.42M5.72M(4.56M)
Effect of Forex Changes(857K)(862K)202K(1.11M)1.44M
Net Change in Cash47.25M(113.23M)96.56M(38.88M)8.99M
Free Cash Flow30.32M17.61M(3.59M)(7.67M)(40.05M)

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.